FR2837708B1 - Utilisation de la 8'-hydroxydihydroergotamine pour la fabrication d'un medicament contre la migraine - Google Patents

Utilisation de la 8'-hydroxydihydroergotamine pour la fabrication d'un medicament contre la migraine

Info

Publication number
FR2837708B1
FR2837708B1 FR0204081A FR0204081A FR2837708B1 FR 2837708 B1 FR2837708 B1 FR 2837708B1 FR 0204081 A FR0204081 A FR 0204081A FR 0204081 A FR0204081 A FR 0204081A FR 2837708 B1 FR2837708 B1 FR 2837708B1
Authority
FR
France
Prior art keywords
hydroxydihydroergotamine
manufacture
medicine against
against migraine
migraine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0204081A
Other languages
English (en)
Other versions
FR2837708A1 (fr
Inventor
Louis Guesnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHWARZ PHARMA LAB
Original Assignee
SCHWARZ PHARMA LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHWARZ PHARMA LAB filed Critical SCHWARZ PHARMA LAB
Priority to FR0204081A priority Critical patent/FR2837708B1/fr
Publication of FR2837708A1 publication Critical patent/FR2837708A1/fr
Application granted granted Critical
Publication of FR2837708B1 publication Critical patent/FR2837708B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0204081A 2002-04-02 2002-04-02 Utilisation de la 8'-hydroxydihydroergotamine pour la fabrication d'un medicament contre la migraine Expired - Lifetime FR2837708B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0204081A FR2837708B1 (fr) 2002-04-02 2002-04-02 Utilisation de la 8'-hydroxydihydroergotamine pour la fabrication d'un medicament contre la migraine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204081A FR2837708B1 (fr) 2002-04-02 2002-04-02 Utilisation de la 8'-hydroxydihydroergotamine pour la fabrication d'un medicament contre la migraine

Publications (2)

Publication Number Publication Date
FR2837708A1 FR2837708A1 (fr) 2003-10-03
FR2837708B1 true FR2837708B1 (fr) 2005-02-04

Family

ID=27839386

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0204081A Expired - Lifetime FR2837708B1 (fr) 2002-04-02 2002-04-02 Utilisation de la 8'-hydroxydihydroergotamine pour la fabrication d'un medicament contre la migraine

Country Status (1)

Country Link
FR (1) FR2837708B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004057338A1 (fr) * 2002-12-23 2004-07-08 Bayer Healthcare Ag Diagnostic et traitement de maladies associees au recepteur 2b (5-hteb) de 5-hydroxytryptamine (serotonine)
CA2895816C (fr) 2012-12-21 2021-02-23 Map Pharmaceuticals, Inc. Composes 8'-hydroxy-dihydroergotamine et compositions associees
US20140179705A1 (en) * 2012-12-21 2014-06-26 Map Pharmaceuticals, Inc. 8'-hydroxy-dihydroergotamine compounds and compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
SK13742001A3 (sk) * 1999-03-26 2002-02-05 Pozen Inc. Vysokoúčinné dihydroergotamínové prostriedky

Also Published As

Publication number Publication date
FR2837708A1 (fr) 2003-10-03

Similar Documents

Publication Publication Date Title
EP1646276A4 (fr) Nebuliseur pour la production d'un medicament aerosol
FR2804959B1 (fr) Utilisation de derives de paullones pour la fabrication de medicaments
AU2003275140A8 (en) Theree-dimensional construct for the design and fabrication of physiological fluidic networks
EP1574229A4 (fr) Film medical
FR2848390B1 (fr) Article chaussant notamment pour l'escalade
FR2802772B1 (fr) Utilisation d'un complexe elicitine-lipide pour la protection des plantes contre les pathogenes
AU2003235798A1 (en) Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation
EP1568691A4 (fr) Accelerateur de production d'erythropoietine
IT1318514B1 (it) Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
MA27173A1 (fr) Utilisation de 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-one substituee pour la fabrication de medicaments a effet inhibiteur sur la lipase pancreatique
IL166257A (en) 2-Amino Compounds Benzothiazole Sulfonamides, and Their Use in the Preparation of HIV Protease Inhibition Drugs
EP1491205A4 (fr) Remede contre l'hypermyotonie
EP1537875A4 (fr) Medicament preventif/curatif pour l'arteriosclerose
FR2837285B1 (fr) Pack d'imagerie ultrasonore
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression
PT1576951E (pt) Formulações para administração rectal de agentes com acção trombolitica
ITRM20030091A1 (it) Procedimento per la produzione di una connessione a tenuta di umidita'.
FR2833967B1 (fr) Utilisation de bacteries lactiques pour la production d'alpha-cetoglutarate
FR2835433B1 (fr) Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2
FR2835905B1 (fr) Bonde d'evacuation
AU2002254742A1 (en) Haplotypes of the aldob gene
FR2826278B1 (fr) Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
FR2866570B1 (fr) Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
UA6580S (uk) Опаковання для ліків «еректил»
FR2837707B1 (fr) Utilisation de la 8'-hydroxydihydroergotamine pour un medicament anxiolytique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20